Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2090
Trial Sponsor
Clinical Trial Start Date
February 9, 2017
0Primary Completion Date
December 30, 2023
0Study Completion Date
December 30, 2023
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Product Surveillance Registry (PSR) - Targeted Drug Delivery (TDD) - SynchroMed II European Post-Market Clinical Follow-up (PMCF)0
Last Updated
November 1, 2023
0Study summary
The purpose of this study is to provide continuing evaluation and reporting of safety and performance of the SynchroMed II Infusion System within its intended use. Data will support post-market surveillance obligations.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
